Articles dans des revues avec comité de lecture (103)
  1. 37. Lardinois, I., Dequanter, D., Lechien, J., Bouland, C., Javadian, R., Rodriguez, A., Loeb, I., Journé, F., & Saussez, S. (2020). Survival and treatment outcome of head and neck cancer patients with pulmonary oligometastases. Clinical otolaryngology. doi:10.1111/coa.13668
  2. 38. Lechien, J., Seminerio, I., Descamps, G., Mat, Q., Mouawad, F., Hans, S., Julieron, M., Dequanter, D., Vanderhaegen, T., Journé, F., & Saussez, S. (2019). Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review. Cells, 8(9). doi:10.3390/cells8091061
  3. 39. Krayem, M., Sabbah, M., Najem, A., Wouters, A., Lardon, F., Simon, S., Sales, F., Journé, F., Awada, A., Ghanem, G. E., & Van Gestel, D. (2019). The benefit of reactivating p53 under MAPK inhibition on the efficacy of radiotherapy in melanoma. Cancers (Basel), 11(8), 1093. doi:10.3390/cancers11081093
  4. 40. Soumoy, L., Kindt, N., Ghanem, G. E., Saussez, S., & Journé, F. (2019). Role of macrophage migration inhibitory factor (Mif) in melanoma. Cancers (Basel), 11(4), 529. doi:10.3390/cancers11040529
  5. 41. Bobin, F., Journé, F., & Lechien, J. (2019). Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes. The Laryngoscope. doi:10.1002/lary.28260
  6. 42. Kindt, N., Descamps, G., Lechien, J., Remmelink, M., Colet, J.-M., Wattiez, R., Berchem, G., Journé, F., & Saussez, S. (2019). Involvement of HPV infection in the release of macrophage migration inhibitory factor in head and neck squamous cell carcinoma. Journal of Clinical Medicine, 8(1), 75. doi:10.3390/jcm8010075
  7. 43. Krayem, M., Najem, A., Journé, F., Morandini, R., Sales, F., Awada, A., & Ghanem, G. E. (2018). Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma. Oncotarget, 9(61), 31888-31903. doi:10.18632/oncotarget.25879
  8. 44. Seminerio, I., Kindt, N., Descamps, G., Bellier, J., Lechien, J., Mat, Q., Pottier, C., Journé, F., & Saussez, S. (2018). High infiltration of CD68+ macrophages is associated with poor prognoses of head and neck squamous cell carcinoma patients and is influenced by human papillomavirus. Oncotarget, 9(13), 11046-11059. doi:10.18632/oncotarget.24306
  9. 45. Perdrix, A., Najem, A., Saussez, S., Awada, A., Journé, F., Ghanem, G. E., & Krayem, M. (2017). PRIMA-1 and PRIMA-1Met (APR-246): From mutant/wild type p53 reactivation to unexpected mechanisms underlying their potent anti-tumor effect in combinatorial therapies. Cancers (Basel), 9(12), 172. doi:10.3390/cancers9120172
  10. 46. Lechien, J., Nassri, A., Kindt, N., Brown, D. N., Journé, F., & Saussez, S. (2017). Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review. Head & neck, 39(12), 2573-2584. doi:10.1002/hed.24939
  11. 47. Kindt, N., Journé, F., Ghanem, G. E., & Saussez, S. (2017). Galectins and carcinogenesis: Their role in head and neck carcinomas and thyroid carcinomas. International journal of molecular sciences, 18(12), 2745. doi:10.3390/ijms18122745
  12. 48. Najem, A., Krayem, M., Perdrix, A., Kerger, J., Awada, A., Journé, F., & Ghanem, G. E. (2017). New drug combination strategies in melanoma: Current status and future directions. Anticancer research, 37(11), 5941-5953. doi:10.21873/anticanres.12041
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>